Back to results
US 8,710,200 B2Granted
Engineered nucleic acids encoding a modified erythropoietin and their expression
AssigneeModerna Therapeutics, Inc.
InventorsJason P. Schrum, Noubar B. Afeyan, Gregory J. Sieczkiewicz, Stephane Bancel, Antonin de Fougerolles, Sayda M. Elbashir
Life of this patent
Estimating the term…
Abstract
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Claims14
An isolated polynucleotide, said polynucleotide comprising SEQ ID NO:
- 7.
Dependencies are inferred from the claim text.